Opiant is a specialty pharmaceutical company developing medicines for addiction and drug overdose. The Company developed NARCANÂŽ (naloxone hydrochloride) Nasal Spray (âNARCANÂŽâ), a treatment to reverse opioid overdose. This product was conceived and developed by the Company, licensed to Adapt Pharma Operations Limited (âAdaptâ), an Ireland based pharmaceutical company in December 2014 and approved by the U.S. Food and Drug Administration (âFDAâ) in November 2015. It is marketed by Adapt. In October 2018, Emergent BioSolutions, Inc. ("EBS") completed its acquisition of Adapt. The Company's current pipeline includes medicines in development for Opioid Overdose Reversal (âOORâ), Alcohol Use Disorder (âAUDâ), Opioid Use Disorder (âOUDâ), and Acute Cannabinoid Overdose (âACOâ). The Company is also pursuing other treatment opportunities within the addiction and drug overdose field. Source
No articles found.
The Juhi Ash Center, located on Fifth Avenue and 61st Street, combines the best of...
The Juhi Ash Center, located on Fifth Avenue an...
We exist to make the first step in a familys path to recovery the right step thro...
We exist to make the first step in a familys p...
The recognized global leader in neuromodulation devices to treat blindness, the co...
The recognized global leader in neuromodulation...
ZBP is a biopharmaceutical company that has developed a proprietary technology to ...
ZBP is a biopharmaceutical company that has dev...
Chiasma is focused on improving the lives of patients who face challenges associat...
Chiasma is focused on improving the lives of pa...
Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company ...
Rocket Pharmaceuticals, Inc. is an emerging, cl...
Titan is a specialty pharmaceuticals company that develops therapeutics for select...
Titan is a specialty pharmaceuticals company th...
Join the National Investor Network and get the latest information with your interests in mind.